STAT - Reporting from the frontiers of health and medicine

Health Tech

Pharmalot

First Opinion

By Menachem Fromer, Paul Varghese, and Robert M. Califf

Politics Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health
Health New research finds unapproved drugs in brain-boosting supplements
First Opinion America’s mental health care system fell short for my brother. Access to that care should be a legal right for all
Pharmalot Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Special Report The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
Novartis sells bonds tied to expanding access to medicines in poor countries
Teladoc’s tussle with Amwell raises questions about defining property rights in digital health

Health

By Amy Sokolow

Politics

Health

Health

By Natalya Ortolano

Health

By Gabrielle Glaser

Heavyweights

Special Report The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
Health Tech When AI is the opposite of sinister: An MIT researcher is held up as model of how algorithms can benefit humanity
First Opinion Human reproductive cloning: The curious incident of the dog in the night-time
First Opinion Fast, low-cost testing is essential for averting a second wave of Covid-19
First Opinion Not all there: My mother’s lobotomy
Exclusive Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says
First Opinion A new self-triage tool can help you decide if you need medical care for Covid-19
Health ‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19